Acute hydrops followed by corneal perforation five years after corneal cross-linking for keratoconus.


Journal

Arquivos brasileiros de oftalmologia
ISSN: 1678-2925
Titre abrégé: Arq Bras Oftalmol
Pays: Brazil
ID NLM: 0400645

Informations de publication

Date de publication:
2023
Historique:
received: 22 03 2021
accepted: 07 10 2021
medline: 27 10 2023
pubmed: 12 5 2022
entrez: 11 5 2022
Statut: epublish

Résumé

We report a case of acute corneal hydrops followed by corneal perforation five years after corneal cross-linking for keratoconus. A healthy 24-year-old female patient underwent Dresden protocol cross-linking in her left eye due to advanced keratoconus. After five years of a stable cornea, she returned with epiphora, blurred vision, and a soft left eye. Acute hydrops and corneal perforation were diagnosed. There was no history of pregnancy, atopy, eye rubbing, trauma, or contact lens use. Local antibiotic and eye patching were applied. Three months after the resolution of the acute episode, she retained useful visual acuity with no need for further surgery. Although cross-linking efficiently halts keratoconus, progression can occur, leading to corneal hydrops and perforation, even in the absence of any risk factors.

Identifiants

pubmed: 35544929
pii: S0004-27492022005006205
doi: 10.5935/0004-2749.20230059
pii:
doi:

Types de publication

Case Reports Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

e20230059

Auteurs

Vesna Jovanovic (V)

Faculty of Medical Dentistry, University of Belgrade, Belgrade, Serbia.
Centre for Microsurgery LaserFocus, Belgrade, Serbia.

Ljubisa Nikolic (L)

Centre for Microsurgery LaserFocus, Belgrade, Serbia.

Theo G Seiler (TG)

Department of Ophthalmology, Inselspital, Bern University Hospital, Bern, Switzerland.
Institut für Refraktive und Ophthalmo-Chirurgie, Zurich, Switzerland.

Mirko R Jankov (MR)

Centre for Microsurgery LaserFocus, Belgrade, Serbia.
Institut für Refraktive und Ophthalmo-Chirurgie, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH